Associated Papers
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Nannya Y et al.
Blood Advances, 2023
36989067 (PubMed )
Supplement: BLOODA_ADV-2022-009564-mmc2.xlsx › SuppTable3
Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations.
Willekens C et al.
Leukemia, 2018
Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.
Ernst T et al.
Leukemia, 2018
CD133 marks a stem cell population that drives human primary myelofibrosis.
Triviai I et al.
Haematologica, 2015
Select a paper to view details